Cardio Diagnostics Holdings, Inc. 8-K

What Happened

• On February 19, 2026 Cardio Diagnostics Holdings, Inc. filed a Form 8‑K (Item 7.01) disclosing an investor conference call held at 3:00 p.m. Central Standard Time. Management discussed corporate updates, recent clinical data, reimbursement progress, and strategic initiatives and long‑term objectives. Presentation materials used on the call are furnished as Exhibit 99.1 to the filing.

Key Details

• Event: Investor conference call on Feb 19, 2026 at 3:00 p.m. CST (Regulation FD disclosure, Item 7.01).
• Topics: corporate updates, recent clinical data, reimbursement progress, strategic initiatives and long‑term objectives.
• Materials: Presentation slides furnished as Exhibit 99.1 to the Form 8‑K.
• Replay: A replay will be available for a limited time at https://www.cstproxy.com/cardiodiagnosticsinc/investorday/2026.

Why It Matters

• The call provides direct management commentary on clinical results and reimbursement progress—key factors for Cardio Diagnostics’ commercialization and potential revenue outlook. Investors can review the furnished presentation and replay to assess the company’s near‑term strategy and milestones without relying on speculation.